The world's first human trial of a drug that can regenerate teeth will begin in a few months, less than a year on from news of its success in animals. This paves the way for the medicine to be commercially available as early as 2030.
The trial, which will take place at Kyoto University Hospital from September to August 2025, will treat 30 males aged 30-64 who are missing at least one molar.
Is only testing on men still a thing in science? Since stuff can have different effects between genders, this could be bad for women.
Yeah of course. But as you’re saying, it’s just a little odd. History shows that focusing on one gender does eventually have bad consequences for the other gender.
ADepending on the science being done, genders are preferred. In many cases it’s men due to less complex chemistry and internal anatomy. Men are more basic to start off with less risk of imbalance or damage if things go unexpectedly. Considering the nature of what’s being done, this isn’t at all odd for this trial. Sciences doesn’t recognise gender bias unless it’s studying gender bias.
Is only testing on men still a thing in science? Since stuff can have different effects between genders, this could be bad for women.
It’s not precluding a subsequent trial that includes women.
Having said that, it is a little odd that it’s a men only trial.
Yeah of course. But as you’re saying, it’s just a little odd. History shows that focusing on one gender does eventually have bad consequences for the other gender.
ADepending on the science being done, genders are preferred. In many cases it’s men due to less complex chemistry and internal anatomy. Men are more basic to start off with less risk of imbalance or damage if things go unexpectedly. Considering the nature of what’s being done, this isn’t at all odd for this trial. Sciences doesn’t recognise gender bias unless it’s studying gender bias.
I can understand it from a very basic level of ‘simple first’ but if you’re doing human trial s you should be on a complex level already